Yeungnam Univ J Med.  2016 Jun;33(1):33-36. 10.12701/yujm.2016.33.1.33.

Metformin induced acute pancreatitis and lactic acidosis in a patient on hemodialysis

• Lee YK
• Lim K
• Hwang SH
• Ahn YH
• Shin GT
• Kim H
• Park IW

• KMID: 2328110
• DOI: http://doi.org/10.12701/yujm.2016.33.1.33

Abstract

Metformin, commonly prescribed for type 2 diabetes, is considered safe with minimal side-effect. Acute pancreatitis is rare but potentially fatal adverse side-effect of metformin. We report a patient on hemodialysis with metformin-related acute pancreatitis and lactic acidosis. A 62-year-old woman with diabetic nephropathy and hypertension presented with nausea and vomiting for a few weeks, followed by epigastric pain. At home, the therapy of 500 mg/day metformin and 50 mg/day sitagliptin was continued, despite symptoms. Laboratory investigations showed metabolic acidosis with high levels of lactate, amylase at 520 U/L (range, 30-110 U/L), and lipase at 1,250 U/L (range, 23-300 U/L). Acute pancreatitis was confirmed by computed tomography. No recognized cause of acute pancreatitis was identified. Metformin was discontinued. Treatment with insulin and intravenous fluids resulted in normalized amylase, lipase, and lactate. When she was re-exposed to sitagliptin, no symptoms were reported.

Keyword

Metformin; Pancreatitis; Lactic acidosis; Diabetes mellitus

MeSH Terms

Acidosis
Acidosis, Lactic*
Amylases
Diabetes Mellitus
Diabetic Nephropathies
Female
Humans
Hypertension
Insulin
Lactic Acid
Lipase
Metformin*
Middle Aged
Nausea
Pancreatitis*
Renal Dialysis*
Sitagliptin Phosphate
Vomiting
Amylases
Insulin
Lactic Acid
Lipase
Metformin
Sitagliptin Phosphate